Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29118449.
- Also identified by DOI 10.1038/nrn.2017.128.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
It is widely recognized that myelination of axons greatly enhances the speed of signal transmission. An exciting new finding is the dynamic communication between axons and their myelin-forming oligodendrocytes, including activity-dependent signalling from axon to myelin. The oligodendrocyte-myelin complex may in turn respond by providing metabolic support or alter subtle myelin properties to modulate action potential propagation. In this Opinion, we discuss what is known regarding the molecular physiology of this novel, synapse-like communication and speculate on potential roles in disease states including multiple sclerosis, schizophrenia and Alzheimer disease. An emerging appreciation of the contribution of white-matter perturbations to neurological dysfunction identifies the axo-myelinic synapse as a potential novel therapeutic target.
Medical subject headings
- Axons
- Brain Diseases
- Myelin Sheath
- Oligodendroglia
- Synaptic Transmission